HUP0300532A3 - Analgesic salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines - Google Patents
Analgesic salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-aminesInfo
- Publication number
- HUP0300532A3 HUP0300532A3 HU0300532A HUP0300532A HUP0300532A3 HU P0300532 A3 HUP0300532 A3 HU P0300532A3 HU 0300532 A HU0300532 A HU 0300532A HU P0300532 A HUP0300532 A HU P0300532A HU P0300532 A3 HUP0300532 A3 HU P0300532A3
- Authority
- HU
- Hungary
- Prior art keywords
- amines
- imidazo
- analgesic
- bicyclic
- salts
- Prior art date
Links
- 230000000202 analgesic effect Effects 0.000 title 1
- 125000002619 bicyclic group Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Addiction (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10019714A DE10019714A1 (en) | 2000-04-20 | 2000-04-20 | Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
PCT/EP2001/003772 WO2001081344A1 (en) | 2000-04-20 | 2001-04-03 | Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0300532A2 HUP0300532A2 (en) | 2003-07-28 |
HUP0300532A3 true HUP0300532A3 (en) | 2009-01-28 |
Family
ID=7639529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0300532A HUP0300532A3 (en) | 2000-04-20 | 2001-04-03 | Analgesic salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
Country Status (30)
Country | Link |
---|---|
US (2) | US7087607B2 (en) |
EP (1) | EP1274709B1 (en) |
JP (1) | JP2003531208A (en) |
KR (1) | KR100756594B1 (en) |
CN (1) | CN1232520C (en) |
AR (1) | AR030559A1 (en) |
AT (1) | ATE277045T1 (en) |
AU (2) | AU2001258305B2 (en) |
BR (1) | BR0110357A (en) |
CA (1) | CA2402808A1 (en) |
CZ (1) | CZ20023476A3 (en) |
DE (2) | DE10019714A1 (en) |
DK (1) | DK1274709T3 (en) |
ES (1) | ES2227186T3 (en) |
HK (1) | HK1052703B (en) |
HU (1) | HUP0300532A3 (en) |
IL (2) | IL152352A0 (en) |
MX (1) | MXPA02009602A (en) |
NO (1) | NO323542B1 (en) |
NZ (1) | NZ521069A (en) |
PE (1) | PE20011213A1 (en) |
PL (1) | PL365676A1 (en) |
PT (1) | PT1274709E (en) |
RU (1) | RU2268888C2 (en) |
SI (1) | SI1274709T1 (en) |
SK (1) | SK15022002A3 (en) |
TR (1) | TR200402755T4 (en) |
UY (1) | UY26675A1 (en) |
WO (1) | WO2001081344A1 (en) |
ZA (1) | ZA200209408B (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10019714A1 (en) | 2000-04-20 | 2002-01-10 | Gruenenthal Gmbh | Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
DE10050663A1 (en) † | 2000-10-13 | 2002-04-18 | Gruenenthal Gmbh | Use of amino-substituted imidazo(1,2-a)pyridine, imidazo(1,2-a)pyrimidine and imidazo(1,2-a)pyrazine derivatives as NO synthase inhibitors, e.g. in treatment of migraine and neurodegenerative diseases |
EP1902056A2 (en) | 2005-05-20 | 2008-03-26 | Array Biopharma, Inc. | Raf inhibitor compounds and methods of use thereof |
TW200800213A (en) | 2005-09-02 | 2008-01-01 | Abbott Lab | Novel imidazo based heterocycles |
EP3417912B1 (en) | 2005-12-23 | 2020-08-12 | ARIAD Pharmaceuticals, Inc. | Bicyclic heteroaryl compounds |
MX2008011684A (en) | 2006-03-17 | 2008-12-12 | Ambit Biosciences Corp | Imidazolothiazole compounds for the treatment of disease. |
WO2007138072A2 (en) * | 2006-05-31 | 2007-12-06 | Galapagos N.V. | Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
US7790741B2 (en) * | 2006-10-06 | 2010-09-07 | Abbott Laboratories | Imidazothiazoles and imidazoxazoles |
US8703492B2 (en) | 2007-04-06 | 2014-04-22 | Qiagen Gaithersburg, Inc. | Open platform hybrid manual-automated sample processing system |
US7985375B2 (en) * | 2007-04-06 | 2011-07-26 | Qiagen Gaithersburg, Inc. | Sample preparation system and method for processing clinical specimens |
KR101572701B1 (en) * | 2007-09-19 | 2015-11-27 | 암비트 바이오사이언시즈 코포레이션 | Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-[4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea, compositions thereof, and uses therewith |
WO2011063139A1 (en) | 2009-11-18 | 2011-05-26 | Qiagen | Laboratory central control unit method and system |
KR200453430Y1 (en) * | 2011-01-10 | 2011-05-03 | 백현숙 | Countertop Shelves |
BR112014026643B1 (en) | 2012-04-26 | 2023-03-07 | Universite De Montreal | IMIDAZOTIADIAZOLE AND IMIDAZOPIRAZINE DERIVATIVES AS PROTEASE-ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR THE TREATMENT OF PLATELET AGGREGATION, THEIR USES AND PHARMACEUTICAL COMPOSITION |
EP2855489B1 (en) | 2012-04-26 | 2017-01-04 | Bristol-Myers Squibb Company | Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation |
KR20150003767A (en) | 2012-04-26 | 2015-01-09 | 브리스톨-마이어스 스큅 컴퍼니 | Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation |
US9598419B1 (en) | 2014-06-24 | 2017-03-21 | Universite De Montreal | Imidazotriazine and imidazodiazine compounds |
US9617279B1 (en) | 2014-06-24 | 2017-04-11 | Bristol-Myers Squibb Company | Imidazooxadiazole compounds |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2857776A (en) | 1955-01-13 | 1958-10-28 | American Metal Prod | Lead screw selectively operable and releasable under load |
US3489755A (en) | 1966-08-03 | 1970-01-13 | Pfizer & Co C | Imidazo (1,2-b) pyridazines |
US3792166A (en) * | 1970-11-16 | 1974-02-12 | American Cyanamid Co | Method of using substituted imidazo (2,1-b)thiazoles as anthelmintic agents |
US3894022A (en) * | 1973-06-25 | 1975-07-08 | Sandoz Ag | Tetracyclic quinazolinones and quinazolinium salts |
JPS5398997A (en) * | 1977-02-09 | 1978-08-29 | Sumitomo Chem Co Ltd | Fused pyridine derivertives and process for their preparation |
GB2039882A (en) * | 1979-01-05 | 1980-08-20 | Ciba Geigy Ag | Bicyclic thiadiaza compounds and their use as medicaments |
DE3269604D1 (en) * | 1981-06-26 | 1986-04-10 | Schering Corp | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
FR2568880B1 (en) * | 1984-08-07 | 1986-12-12 | Synthelabo | IMIDAZO ACYLAMINOMETHYL-3 DERIVATIVES (1,2-A) PYRIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
FR2627491B1 (en) | 1988-02-18 | 1992-01-24 | Roussel Uclaf | NOVEL DERIVATIVES OF BENZOCYCLOHEXANE AND BENZOCYCLOHEPTANE AS WELL AS THEIR SALTS, THEIR PREPARATION PROCESS AND THE NOVEL INTERMEDIATES THUS OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM |
JPH0753730B2 (en) * | 1988-07-26 | 1995-06-07 | 三共株式会社 | Imidazopyrazole derivative |
US5536853A (en) * | 1994-04-11 | 1996-07-16 | Chiron Corporation | Opiate receptor ligands |
DE10019714A1 (en) | 2000-04-20 | 2002-01-10 | Gruenenthal Gmbh | Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
-
2000
- 2000-04-20 DE DE10019714A patent/DE10019714A1/en not_active Withdrawn
-
2001
- 2001-04-03 CZ CZ20023476A patent/CZ20023476A3/en unknown
- 2001-04-03 KR KR1020027014037A patent/KR100756594B1/en not_active IP Right Cessation
- 2001-04-03 SK SK1502-2002A patent/SK15022002A3/en unknown
- 2001-04-03 PT PT01931560T patent/PT1274709E/en unknown
- 2001-04-03 CN CNB018079423A patent/CN1232520C/en not_active Expired - Fee Related
- 2001-04-03 DE DE50103764T patent/DE50103764D1/en not_active Expired - Lifetime
- 2001-04-03 DK DK01931560T patent/DK1274709T3/en active
- 2001-04-03 PL PL01365676A patent/PL365676A1/en not_active Application Discontinuation
- 2001-04-03 EP EP01931560A patent/EP1274709B1/en not_active Expired - Lifetime
- 2001-04-03 MX MXPA02009602A patent/MXPA02009602A/en active IP Right Grant
- 2001-04-03 RU RU2002130245/04A patent/RU2268888C2/en active
- 2001-04-03 HU HU0300532A patent/HUP0300532A3/en unknown
- 2001-04-03 JP JP2001578434A patent/JP2003531208A/en not_active Withdrawn
- 2001-04-03 AU AU2001258305A patent/AU2001258305B2/en not_active Ceased
- 2001-04-03 BR BR0110357-1A patent/BR0110357A/en not_active Application Discontinuation
- 2001-04-03 WO PCT/EP2001/003772 patent/WO2001081344A1/en active IP Right Grant
- 2001-04-03 AU AU5830501A patent/AU5830501A/en active Pending
- 2001-04-03 NZ NZ521069A patent/NZ521069A/en unknown
- 2001-04-03 CA CA002402808A patent/CA2402808A1/en not_active Abandoned
- 2001-04-03 AT AT01931560T patent/ATE277045T1/en active
- 2001-04-03 ES ES01931560T patent/ES2227186T3/en not_active Expired - Lifetime
- 2001-04-03 IL IL15235201A patent/IL152352A0/en unknown
- 2001-04-03 SI SI200130236T patent/SI1274709T1/en unknown
- 2001-04-03 TR TR2004/02755T patent/TR200402755T4/en unknown
- 2001-04-17 AR ARP010101796A patent/AR030559A1/en unknown
- 2001-04-19 PE PE2001000355A patent/PE20011213A1/en not_active Application Discontinuation
- 2001-04-20 UY UY26675A patent/UY26675A1/en not_active Application Discontinuation
-
2002
- 2002-10-07 NO NO20024838A patent/NO323542B1/en not_active IP Right Cessation
- 2002-10-17 IL IL152352A patent/IL152352A/en active IP Right Grant
- 2002-10-18 US US10/273,344 patent/US7087607B2/en not_active Expired - Fee Related
- 2002-11-19 ZA ZA200209408A patent/ZA200209408B/en unknown
-
2003
- 2003-07-10 HK HK03105003.1A patent/HK1052703B/en not_active IP Right Cessation
-
2006
- 2006-06-06 US US11/447,141 patent/US7153873B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0300532A3 (en) | Analgesic salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines | |
GB2356348B (en) | Potentiation of the analgesic effect of Buprenorphine | |
AU2003296954A8 (en) | Analgesic combination comprising nalbuphine | |
IL152560A0 (en) | Ring fixator | |
GB0028429D0 (en) | Therapy | |
AU2001258305A1 (en) | Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines | |
SI1337521T1 (en) | Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents | |
IL157662A0 (en) | N-but-3-enyl norbuprenorphine and its use as analgesic | |
GB0105613D0 (en) | Pharmaceutically effective compounds and their use | |
GB0119025D0 (en) | Compounds and their therapeutic use | |
EP1407771A4 (en) | Sophoridine and use thereof as an analgesic | |
GB0018887D0 (en) | Compound and their therapeutic use | |
GB2376943B (en) | Compounds and their therapeutic use | |
GB0024517D0 (en) | Use of medicaments | |
GB0112237D0 (en) | Compounds and their therapeutic use | |
AU6884801A (en) | Therapeutic compounds and methods | |
GB0021927D0 (en) | Use of pharmaceutical combination | |
SI1309589T1 (en) | Urea compounds and methods of uses | |
GB0030058D0 (en) | Use of compounds in therapy | |
GB0017625D0 (en) | Use of compounds in therapy | |
GB0012945D0 (en) | Use of compounds in therapy | |
GB0018886D0 (en) | Compounds and their therapeutic use | |
GB0018888D0 (en) | Compounds and their therapeutic use | |
GB0018885D0 (en) | Compounds and their therapeutic use | |
GB0118627D0 (en) | Use of compounds in therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |